ICD-10 codes used to identify adverse drug events in administrative data: a systematic review

Background Adverse drug events, the unintended and harmful effects of medications, are important outcome measures in health services research. Yet no universally accepted set of International Classification of Diseases (ICD) revision 10 codes or coding algorithms exists to ensure their consistent identification in administrative data. Our objective was to synthesize a comprehensive set of ICD-10 codes used to identify adverse drug events. Methods We developed a systematic search strategy and applied it to five electronic reference databases. We searched relevant medical journals, conference proceedings, electronic grey literature and bibliographies of relevant studies, and contacted content experts for unpublished studies. One author reviewed the titles and abstracts for inclusion and exclusion criteria. Two authors reviewed eligible full-text articles and abstracted data in duplicate. Data were synthesized in a qualitative manner. Results Of 4241 titles identified, 41 were included. We found a total of 827 ICD-10 codes that have been used in the medical literature to identify adverse drug events. The median number of codes used to search for adverse drug events was 190 (IQR 156–289) with a large degree of variability between studies in the numbers and types of codes used. Authors commonly used external injury (Y40.0–59.9) and disease manifestation codes. Only two papers reported on the sensitivity of their code set. Conclusions Substantial variability exists in the methods used to identify adverse drug events in administrative data. Our work may serve as a point of reference for future research and consensus building in this area.

[1]  K. Hauck,et al.  How Dangerous is a Day in Hospital?: A Model of Adverse Events and Length of Stay for Medical Inpatients , 2011, Medical care.

[2]  Josip Car,et al.  Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998–2005 , 2007, BMC clinical pharmacology.

[3]  Analyzing Prescription Drugs as Causes of Death on Death Certificates , 2004, Public health reports.

[4]  P. Waller,et al.  Comparison of hospital episodes with 'drug-induced' disorders and spontaneously reported adverse drug reactions. , 2006, British journal of clinical pharmacology.

[5]  C. Richards,et al.  Emergency hospitalizations for adverse drug events in older Americans. , 2011, The New England journal of medicine.

[6]  Azeem Majeed,et al.  Ten-year trends in hospital admissions for adverse drug reactions in England 1999–2009 , 2010, Journal of the Royal Society of Medicine.

[7]  Jude L. Michel,et al.  A classification of hospital‐acquired diagnoses for use with routine hospital data , 2009, The Medical journal of Australia.

[8]  Christel L Burgess,et al.  Adverse drug reactions in older Australians, 1981–2002 , 2005, The Medical journal of Australia.

[9]  R E Ferner,et al.  Adverse drug reactions in patients admitted to hospital identified by discharge ICD-10 codes and by spontaneous reports. , 2001, British journal of clinical pharmacology.

[10]  D. Bates,et al.  Incidence and preventability of adverse drug events among older persons in the ambulatory setting. , 2003, JAMA.

[11]  Jürgen Stausberg,et al.  Evaluating adverse drug event reporting in administrative data from emergency departments: a validation study , 2013, BMC Health Services Research.

[12]  Jeffrey L. Schnipper,et al.  Hospital-Based Medication Reconciliation Practices , 2016 .

[13]  A. Shaheen,et al.  Validation of ICD-9-CM/ICD-10 coding algorithms for the identification of patients with acetaminophen overdose and hepatotoxicity using administrative data , 2007, BMC Health Services Research.

[14]  F. Chapuis,et al.  Heparin-Induced Thrombocytopenia: An Estimate of the Average Cost in the Hospital Setting in France , 2009, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[15]  D W Bates,et al.  Drugs and adverse drug reactions: how worried should we be? , 1998, JAMA.

[16]  R. Raschke,et al.  A computer alert system to prevent injury from adverse drug events: development and evaluation in a community teaching hospital. , 1998, JAMA.

[17]  M. Lapeyre-Mestre,et al.  Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital. , 2006, British journal of clinical pharmacology.

[18]  G. Shepherd,et al.  Adverse Drug Reaction Deaths Reported in United States Vital Statistics, 1999-2006 , 2012, The Annals of pharmacotherapy.

[19]  W. Runciman,et al.  A classification for adverse drug events. , 1999, Journal of quality in clinical practice.

[20]  L. McKeown,et al.  Unintentional and undetermined poisoning deaths--11 states, 1990-2001. , 2004, MMWR. Morbidity and mortality weekly report.

[21]  Sebastian Schneeweiss,et al.  Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study , 2002, European Journal of Clinical Pharmacology.

[22]  P. Barach,et al.  Clarifying Adverse Drug Events: A Clinician's Guide to Terminology, Documentation, and Reporting , 2004, Annals of Internal Medicine.

[23]  Boris Sobolev,et al.  Outcomes of emergency department patients presenting with adverse drug events. , 2011, Annals of emergency medicine.

[24]  W. Gaus,et al.  Identification of Adverse Drug Reactions by Evaluation of a Prescription Database, Demonstrated for “Risk of Bleeding” , 2005, Methods of Information in Medicine.

[25]  P. McKeigue,et al.  Case ascertainment and estimated incidence of drug-induced long-QT syndrome: study in Southwest France. , 2008, British journal of clinical pharmacology.

[26]  A. Robicsek,et al.  5 Million Lives Campaign , 2008 .

[27]  I. Edwards,et al.  Adverse drug reactions: definitions, diagnosis, and management , 2000, The Lancet.

[28]  E. Bjornsson,et al.  The predictors of complications in patients with drug‐induced liver injury caused by antimicrobial agents , 2010, Alimentary pharmacology & therapeutics.

[29]  P T Davis Adverse drug events in hospitalized patients. , 1997, JAMA.

[30]  Barbara H. Lang,et al.  Epidemiology of Anesthesia-related Mortality in the United States, 1999–2005 , 2009, Anesthesiology.

[31]  D. Wysowski,et al.  Deaths attributed to X-ray contrast media on U.S. death certificates. , 2006, AJR. American journal of roentgenology.

[32]  Identification of Adverse Drug Reactions Using the ICD‐10 Australian Modification Clinical Coding Surveillance , 2009 .

[33]  F. Hamada,et al.  Acetyl-L-carnitine ameliorates caerulein-induced acute pancreatitis in rats. , 2009, Basic & clinical pharmacology & toxicology.

[34]  J. Stausberg,et al.  Identification of adverse drug events: the use of ICD-10 coded diagnoses in routine hospital data. , 2010, Deutsches Arzteblatt international.

[35]  C. Holman,et al.  Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study , 2009, BMJ : British Medical Journal.

[36]  Jürgen Stausberg,et al.  Drug-related admissions and hospital-acquired adverse drug events in Germany: a longitudinal analysis from 2003 to 2007 of ICD-10-coded routine data , 2011, BMC health services research.

[37]  C. Holman,et al.  Repeat adverse drug reactions causing hospitalization in older Australians: a population-based longitudinal study 1980-2003. , 2007, British journal of clinical pharmacology.

[38]  Stephanie K. Mueller,et al.  Hospital-based medication reconciliation practices: a systematic review. , 2012, Archives of internal medicine.

[39]  Samy Suissa,et al.  Primer: administrative health databases in observational studies of drug effects—advantages and disadvantages , 2007, Nature Clinical Practice Rheumatology.

[40]  S. Schroeder,et al.  How Many Hours Is Enough? An Old Profession Meets a New Generation , 2004, Annals of Internal Medicine.

[41]  D. Wysowski,et al.  Surveillance of Prescription Drug-Related Mortality Using Death Certificate Data , 2007, Drug safety.

[42]  R S Evans,et al.  Computerized surveillance of adverse drug events in hospital patients* , 2005, Quality and Safety in Health Care.

[43]  J. Kaltschmidt,et al.  Prescribing errors in patients with documented drug allergies: comparison of ICD-10 coding and written patient notes , 2009, Pharmacy World & Science.

[44]  P. Ruutu,et al.  Hospitalizations and Deaths Associated with Clostridium difficile Infection, Finland, 1996–2004 , 2009, Emerging infectious diseases.

[45]  D. Moneret-vautrin,et al.  Epidemiology of life‐threatening and lethal anaphylaxis: a review , 2005, Allergy.

[46]  Jonathan M. Teich,et al.  Research Paper: Identifying Adverse Drug Events: Development of a Computer-based Monitor and Comparison with Chart Review and Stimulated Voluntary Report , 1998, J. Am. Medical Informatics Assoc..

[47]  R J Glynn,et al.  Assessing the Comparative Effectiveness of Newly Marketed Medications: Methodological Challenges and Implications for Drug Development , 2011, Clinical pharmacology and therapeutics.

[48]  M. Afilalo,et al.  Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. , 2001, Annals of emergency medicine.

[49]  M. Pirmohamed,et al.  Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients , 2004, BMJ : British Medical Journal.

[50]  A. Egberts,et al.  Adverse drug events in hospitalized patients A comparison of doctors, nurses and patients as sources of reports , 1999, European Journal of Clinical Pharmacology.

[51]  K. Davison,et al.  DRUGS: International Drug Monitoring: The Role of National Centres. , 1973, British Journal of Psychiatry.

[52]  P. Noyce,et al.  Hospital Admissions Associated with Adverse Drug Reactions: A Systematic Review of Prospective Observational Studies , 2008, The Annals of pharmacotherapy.

[53]  D. Levitt Heterogeneity of human adipose blood flow , 2007, BMC clinical pharmacology.

[54]  D. Phillips,et al.  A steep increase in domestic fatal medication errors with use of alcohol and/or street drugs. , 2008, Archives of internal medicine.

[55]  Catherine M. Dormitzer,et al.  Use of parenteral iron products and serious anaphylactic‐type reactions , 2010, American journal of hematology.

[56]  Vicki L Burt,et al.  Prescription drug use continues to increase: U.S. prescription drug data for 2007-2008. , 2010, NCHS data brief.

[57]  P. Waller,et al.  Hospital admissions for 'drug-induced' disorders in England: a study using the Hospital Episodes Statistics (HES) database. , 2005, British journal of clinical pharmacology.

[58]  J. Edwards,et al.  Extra Adverse drug reactions in hospital patients A systematic review of the prospective and retrospective studies , 2002 .

[59]  William B Runciman,et al.  Adverse drug events and medication errors in Australia. , 2003, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[60]  J. Buechner Adverse drug reactions in hospital patients. , 1998, Medicine and health, Rhode Island.

[61]  Yoon Kim,et al.  Evaluation of a computer-based adverse-drug-event monitor. , 2008, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[62]  Katherine E Henson,et al.  Risk of Suicide After Cancer Diagnosis in England , 2018, JAMA psychiatry.

[63]  J. Brubacher,et al.  Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study , 2008, Canadian Medical Association Journal.

[64]  Chen Wu Adverse Drug Reactions in the Emergency Department Population in Ontario: Analysis of National Ambulatory Care Reporting System and Discharge Abstract Database 2003-2007 , 2010 .

[65]  Richard E Gliklich,et al.  GRACE principles: recognizing high-quality observational studies of comparative effectiveness. , 2010, The American journal of managed care.

[66]  Scott R. Smith,et al.  Developing a Protocol for Observational Comparative Effectiveness Research: A User's Guide , 2013 .

[67]  Shannon A. Sims,et al.  Surveillance of methadone-related adverse drug events using multiple public health data sources , 2007, J. Biomed. Informatics.

[68]  D. Wysowski,et al.  Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. , 2007, Archives of internal medicine.

[69]  P. Corey,et al.  Incidence of Adverse Drug Reactions in Hospitalized Patients , 2012 .

[70]  D. Classen,et al.  Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. , 1997, JAMA.